Lambda proudly marks yet another consecutive GLP compliance certification at Ahmedabad facility since 2014, by the National GLP Compliance Monitoring Authority (NGCMA).

Lambda’s unwavering dedication to quality and excellence is reflected in this consecutive certification, since 2014. This achievement underscores the relentless efforts and outstanding contributions of Lambda’s scientific team in upholding the highest standards of good laboratory practices.

Lambda Therapeutic Research proudly announces yet another significant milestone as its Ahmedabad facility receives GLP compliance certification from the National GLP Compliance Monitoring Authority (NGCMA), under the Department of Sciences and Technology, Government of India.

The certification highlights the Ahmedabad facility’s capability to conduct a wide range of activities, including analytical and clinical chemistry testing, bioanalysis, method development, and method validation, all in strict adherence to GLP standards and OECD Principles of GLP. This recognition not only solidifies Lambda’s commitment to maintaining international standards but also reinforces its dedication to integrity in laboratory practices. Lambda continues to lead the industry with its focus on quality, excellence, and adherence to regulatory standards. This achievement is a testament to Lambda’s ongoing commitment to delivering reliable and high-quality services to its clients worldwide.

Lambda Therapeutic Research offers a wide range of bioanalytical capabilities specializing in cell-based assays, biomarkers, immunogenicity, and pharmacokinetics (PK). With state-of-the-art facilities and a team of experienced scientists, Lambda provides comprehensive solutions for the analysis of small molecules, biomarkers, biologics, and therapeutic trace elements.